/ NOT FOR USE TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./
TORONTO, February 17, 2021 / CNW / – Tha Pathway Health, Corp. (“Pathway” or the “Company”) is pleased to announce a research collaboration with Tilray Canada Ltd, a subsidiary of Tilray, Inc., one of the world ‘s leading companies in research, manufacturing. and distribution of pharmaceutical cannabis. The Medical Cannabis Study in Older Patients (MCOPS) is a Tilray-supported 6-month observational study that examines the impact of medical cannabis on chronic pain, sleep, quality of life, and medication use in older patients. 50 years old. .
Pathway Chief Commercial Officer, Kim Wei, he said, “Pathway Health is delighted to be working with Tilray on this important study that we believe will advance our knowledge of the potential benefits of medical cannabis for the health conditions. all or some of that. “
Philippe Lucas, VP of Tilray’s Global Patient Research and Accessibility, says, “Older people are among the fastest growing group of medical cannabis patients in Canada and worldwide. Prospective multi-site studies such as MCOPS can provide a better understanding of the current use of medical cannabis by elderly patients, and the potential harms and benefits of this particular population. “
About Pathway Health Corp.
Pathway Health is one of the largest providers of out-of-hospital pain management services in Canada. The Company owns 9 community-based clinics across 4 areas where their team of health professionals work together to help patients through a variety of evidence-based approaches. Pathway Health patient care programs use an interdisciplinary approach led by trained pain specialists, physical and occupational therapists, psychologists, nurses, and other health care providers. Pathway Health has also developed experience in harm reduction where pharmaceutical cannabis is used as an alternative to traditional opioids.
For more information, visit the Pathway Health website: www.pathwayhealth.ca
Notice of forward-looking statements
Some statements in this press release are positive and intended to be considered. Forward-looking statements are not based on historical facts, but on current expectations and predictions about future events and are therefore subject to risks and uncertainties that could have real consequences. effectively differentiated from the future results expressed or explained by the forward-looking statements. . These statements can be broadly identified by forward-looking words such as “may”, “should”, “could”, “would”, “expect”, “estimate ”,“ Plan ”,“ expectation ”,“ expectation ””, “believe”, “work on” or “continue”, or the negative or similar changes. There are a number of possible dangers and uncertainties. actual outcomes and Pathway plans and objectives to be significantly different from those set out in the forward-looking information, including: COVID-related business disruption risks- 19; regulatory risks, including those related to healthcare, privacy, and data security; and integration risks associated with new businesses. Real future outcomes and events could be quite different from the expected ones in information.These are these and all forward-looking written and oral information based on regulatory estimates and opinions on the dates to be made and is fully warranted by this warning. However, in accordance with the requirements of the law, the Company does not intend to update these forward-looking statements.
CORPORATE SOURCES Healthcare Corp.
For further information: Wayne Cockburn, President, [email protected], (905) 505-0770
Related Links
pathhealth.ca